To study the effect of Safuf-e-Zaranbad in patients with Non-Alcoholic Fatty Liver Disease

Phase 2

• Conditions: Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

• Registration Number: CTRI/2023/03/050355
• Lead Sponsor: Central Council for Research in Unani Medicine New Delhi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. USG documented grade 1 (mild) and grade 2 (moderate) non-alcoholic fatty liver disease.

2. Patients complaining dull ache or heaviness in the right upper quadrant (right hypochondrium).

3. Patients having symptoms like maliase and dyspepsia.

4. Irrespective of any gender.

5. Patients in the age group of 18-65 years.

6. Patients who have BMI < 34.9Kg/m2.

7. Those patients who are willing to give consent.

Exclusion Criteria

1. Patients having USG documented fatty liver Grade 3 or above.

2. Patients with history of Alcoholic fatty liver disease.

3. Patients with history of chronic renal disorders.

4. Patients below the age of 18 and above the age of 65 years respectively.

5. Patients with BMI >34.9 kg/m2.

6. Patients priorly diagnosed with cholecystitis and cholelithiasis.

7. Patients having uncontrolled diabetes mellitus.

8. History of liver transplantation.

9. Lactating mother and pregnant women.

10. Patients already diagnosed with liver disorders other than non alcoholic fatty liver disease like Cirrhosis, viral hepatitis etc.

11. Patients who fail to give consent.

12. Patients taking lipid lowering drugs/ statins.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. USG abdomen (Liver Span) <br/ ><br>2. LFT (Sr. Bilirubin, SGOT, SGPT, ALP) <br/ ><br>3. Lipid profile ( Sr. Triglycerides, Sr. Cholesterol, LDL, VLDL, HDL)Timepoint: 60 days

Secondary Outcome Measures

Name	Time	Method
1.Maliase <br/ ><br>2. Anorexia <br/ ><br>3. Dull ache in the right hypochondrium <br/ ><br>4. DyspepsiaTimepoint: 60 days